CEACAM5 and pachyonychia congenita: Carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA) are the two most widely used markers for early diagnosis of PC, although only CA19-9 has received FDA-approval for pancreatic tumor evaluation.